This investigation addressed the role of major histocompatibility complex-encoded class I molecules in the activation and proliferation ofhuman lymphocytes. We studied the effect of antibodies specific for HLA-A and HLA-B locus gene products on mitogen-stimulated peripheral blood mononuclear cell (PBMC) pubpopulations. Three individually derived, well-characterized anti-HLA class I monoclonal antibodies were demonstrated to inhibit the proliferation of human PBMC stimulated by either OKT3 or the calcium ionophore ionomycin. The antibody directed against HLA-A, -B, and -C locus gene products (W6/32) and the antibody directed against HLA-B locus gene products (4E) inhibited proliferation induced by either mnitogen by 70-90%. The HLA-A locus-specific antibody (131), thougli inhibiting ionomycin-induced proliferation by 80-90%; wks much less effective when OKT3 was the stimulus. The inhibition affected T4+ and T8+ cells and was not mediated by DR' accessory cells. The inhibitory effect of these antibodies was Alsociated with a decrease in the level of interleukin 2 activity present in culture supernatants, decreased interleikih 2 receptor expression, and decreased transferrmn receptor expression and was not overcome by the addition of exogenous interleukin 2. Our results suggest that HLA class I molecules are directly involved in the early critical events of humad lymphocyte activation and proliferation.
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The gene products encoded within the major histocompatibility complex (MHC) are considered central to the regulation of immune responses (1, 2) . Whereas MHC class II antigens are important in antigen presentation and in antigen-specific interactions between T cells and macrophages (3) , MHC class I antigens are largely involved in antigen recognition by cytolytic T lymphocytes (1, 4, 5) . Antibodies to MHC class I antigens have been shown to block allogeneic and virusspecific cytotoxic T-cell responses (5) . More recently, we have found that anti-MHt class I antibodies also modulate natural killer cell function and affect the interleukin 2 (IL-2)-dependent proliferation of a cloned line of human natural killer cells (6, 7) . Despite the many activities associated with MHC class I molecules, the mechanism(s) of action is still unknown.
Since discrete, identifiable steps in the activation pathway of human T lymphocytes have been well defined (reviewed in ref. 8) , we chose to study the effect of anti-HLA class I antibodies on the activation of peripheral blood mononuclear cell (PBMC) subpopulations. Three anti-HLA class I monoclonal antibodies, W6/32 (anti-HLA-A, -B, -C) (9) , 131 (anti-HLA-A) (6, 10) , and 4E (anti-HLA-B) (11) , are shown to inhibit the proliferation of human PBMC stimulated by either OKT3 or the calcium ionophore ionomycin. These results indicate the potential role of MHC class I molecules in lymphocyte activation.
MATERIALS AND METHODS
Monoclonal Antibodies. The anti-human lymphocyte antibodies OKT3, OKT4, OKT8, OKT11, OKIa*1 (anti-HLA DR), and fluorescein isothiocyanate (FITC)-conjugated OKT9 (anti-transferrin receptor) were obtained from Ortho Diagnostics. R3-367 is an affinity-purified murine IgG2a monoclonal antibody that recognizes the 3-nitro-4-hydroxyphenol hapten and was provided by C. Cowing (12) . Antibody to the IL-2 receptor (anti-Tac) was the gift of T. Waldmann (13, 14) .
Monoclonal antibody 131 was prepared as described elsewhere (6) . Antibody 131 reacts exclusively with human class I HLA-A locus antigens (6, 10) . Monoclonal antibody W6/32 was provided by J. Strominger. W6/32 recognizes a monomorphic determinant on all human class I HLA-A, -B, and -C antigens (9) . Antibody 4E recognizes HLA-B locus gene products and was provided by S. Y. Yang (11) . All HLAspecific antibodies were stored in Hanks' balanced salt solution at 40C throughout these experiments.
Biotin-conjugated forms of R3-367 and anti-Tac were prepared by the succinimide ester method as described (15) .
Lymphocyte Proliferation Assay. PBMC, obtained by standard Ficoll/Hypaque density-gradient centrifugation of fresh blood (16) , were suspended at 5 x 105 cells per ml in RPMI 1640 medium supplemented with penicillin (100 units/ml), streptomycin (100 units/ml), neomycin (50 ,g/ml), kanamycin (200 jtg/ml), L-glutamine (2.0 mM), and 10% (vol/vol) heat-inactivated pooled human serum (hereinafter designated complete medium). Reagents were added to cultures at the following final concentrations: OKT3, 250 ng/ml; ionomycin (Calbiochem), 5 ,ug/ml; phytohemagglutinin M (PHA-M) (Difco), 25 ,ug/ml; and phorbol 12-myristate 13-acetate (PMA) ( Lymphokine Preparation 'and IL-2 Assay. Immunoaffinitypurified human IL-2 (gift of R.-Robb) was prepared from the JURKAT cell line as described (18) . Supemnatants containing IL-2 activity were derived from the MLA-144 gibbon ape cell line as described by Rabin et al. (19) . Before use these supernatants were ultracentrifuged at 100,000 x g for 2 hr to remove gibbon ape leukemia virus and filtered through sterile 0.2-pAm Millipore filters (Nalgene). Unconcentrated supernatants contained == 100 units of IL-2 activity per ml. IL-2 preparations were tested for activity in a standard bioassay using the IL-2-dependent murine cell line CTLL (20) Thus, W6/32 (anti-HLA-A, -B, -C) and 4E (anti-HLA-B) antibodies recognize distinct proteins on the cell surface (6, (9) (10) (11) 22) , (ii) 131, W6/32, and 4E induce significant inhibition when added 40 hr after the onset of cell culture (unpublished data), and (iii) these antibodies also inhibit ionophoreinduced proliferation. Hence, these antibodies probably do not interfere with an antigen recognition event.
We also found that anti-HLA class I antibodies inhibit mitogen-induced proliferation of lymphocytes depleted of either T4+ or T8+ cells and that these antibodies are equally effective in the presence and absence of accessory cells. It is therefore likely that the inhibitory activity results from a direct interaction of the antibody with the responding cell.
In PBMC cultures stimulated by OKT3, antibodies 131, W6/32, and 4E not only reduce the level of IL-2 activity in culture supernatants but also decrease the percentage of cells expressing IL-2 and transferrin receptors. Since IL-2 can influence the level of IL-2 receptor expression (21, 23) , it was conceivable that our results could be consequent to an effect of the antibodies solely on IL-2 production (24). However, the inhibitory activity of these antibodies was unaffected by the addition to the cultures of relatively high levels of IL-2. These observations are consistent with the hypothesis that HLA class I molecules are involved in (an) critical event(s), such as activation of protein kinase C, necessary for lymphocyte proliferation (25, 26 ). An alternative, but not mutually exclusive, explanation is that HLA class I molecules are important at more than one point in the cell-activation pathway.
Previous studies from this laboratory have demonstrated that anti-HLA class I monoclonal antibodies inhibit the IL-2-dependent proliferation of a cloned line of natural killer cells (8) . Similarly, anti-rat MHC class I monoclonal antibodies inhibit the IL-2-dependent proliferation of rat T lymphoblasts (27) . Although the mechanism of inhibition was (1986) not fully addressed in either study, it is interesting that both human and rat lymphocytes, in antigen-independent systems, are sensitive to anti-MHC class I antibodies.
The inhibition caused by antibodies reacting with HLA class I molecules contrasts to that observed when lectin mitogen-stimulated PBMC are cultured with antibodies that bind the sheep erythrocyte receptor (anti-p50) (23, 28, 29) in that the inhibition caused by anti-p50 antibodies is overcome by exogenous IL-2, which restores proliferation and IL-2 receptor expression. The inhibitory effect of 131, W6/32, and 4E also contrasts to that observed when antibodies that recognize /32-microglobulin are used to inhibit a primary mixed lymphocyte culture (30) . Similar to the inhibition caused by anti-p50 antibodies, IL-2 also abrogates the inhibitory effect of anti-p2-microglobulin monoclonal antibodies (30) . We cannot rule out the possibility that the apparent disparity between these antibodies and 131, W6/32, and 4E has resulted from the different experimental systems employed. However, preliminary experiments using 131, W6/32, and 4E to inhibit primary mixed lymphocyte cultures and lectin mitogen-stimulated proliferation indicate that anti-HLA class I antibodies alter cell activation in a manner distinct from that of sheep erythrocyte receptor and P2-microglobulin specific antibodies. Whereas the latter cellsurface antigens may have a primary role only in IL-2 elaboration, HLA class I cell-surface proteins appear to be involved in multiple aspects of cell activation.
Antibody 131 (anti-HLA-A) is a less effective inhibitor than antibodies W6/32 (anti-HLA-A, -B, -C) and 4E (anti-HLA-B) when OKT3 is used as a mitogen but is equivalent to antibodies W6/32 and 4E when ionomycin is used to induce proliferation. To our knowledge, no previous reports suggest that different HLA class I gene products have different functional significance in cell activation. Whereas HLA-B and -C locus products may be involved in multiple aspects of lymphocyte activation, HLA-A locus products may be important only in Ca2+-dependent activation events. This not only supports previous work indicating that human lymphocytes have multiple pathways of activation but also suggests that the differences between activation pathways may be discernible through the use of these antibodies (31) (32) (33) .
These data suggest that HLA class I molecules may have an important regulatory function in the activation and cell cycle progression of human PBMC. These findings are particularly interesting when considered in the context of several recent reports demonstrating that certain neoplastic cells have alterations in their cell-surface MHC class I molecules (34) (35) (36) . MHC class I molecules have also been shown to associate with molecules important in cell growth, such as the epidermal growth factor receptor on fibroblasts and the insulin receptor on murine liver cells (37, 38) . This indicates that MHC class I molecules may be directly involved in the growth of other cell types. It will therefore be interesting to identify the natural ligand(s) for this class of proteins and to determine whether it is a positive or negative regulator of cell growth.
